Cumulative effect of impaired fasting glucose on the risk of dementia in middle-aged and elderly people: a nationwide cohort study.

Sci Rep

Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.

Published: November 2023

The relationship between prediabetes and dementia remains controversial. We aimed to examine the association between cumulative exposure to impaired fasting glucose (IFG) and the risk of dementia in the general population. 1,463,066 middle-aged and elderly subjects who had had health examinations for four consecutive years were identified from a Korean nationwide population-based cohort database. IFG was defined as fasting blood glucose 100-125 mg/dL, and the risk of dementia-according to the number of IFG exposure (range 0-4)-was analyzed using the multivariable Cox proportional-hazards model. During the median 6.4 years of follow-up, 7614 cases of all-cause dementia, 5603 cases of Alzheimer's disease, and 1257 cases of vascular dementia occurred. There was a significant trend towards a higher risk of all-cause dementia (P for trend = 0.014) and Alzheimer's disease ( Pfor trend = 0.005) according to the cumulative exposure to IFG, but with a modest (approximately 7-14%) increase in the hazards. A significant stepwise increase in the risk of all-cause dementia and Alzheimer's disease was seen in non-obese subjects, whereas no significant association was observed in obese subjects. This study supports the association between prediabetes and incident dementia and emphasizes that even mild hyperglycemia should not be overlooked.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667225PMC
http://dx.doi.org/10.1038/s41598-023-47566-yDOI Listing

Publication Analysis

Top Keywords

all-cause dementia
12
alzheimer's disease
12
impaired fasting
8
fasting glucose
8
dementia
8
risk dementia
8
middle-aged elderly
8
cumulative exposure
8
risk all-cause
8
risk
5

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Laboratory of Behavioral Neuroscience, National Institute on Aging, Intramural Research Program, Baltimore, MD, USA.

Background: Growth/differentiation factor-15 (GDF15) has been associated with dementia risk, yet its predictive value across cohorts and sub-population, as well as its relationship with endophenotypes relevant to dementia, remains unknown.

Methods: Using the Atherosclerosis Risk in Communities (ARIC) study as the discovery cohort, we examined the relationship between plasma GDF15 levels (SomaScan) and risk for incident all-cause dementia (ACD) in late-life (N=4,287, 7-year follow-up, M=75±5) and in midlife (N=11,595, 20-year follow-up, M=57±6). Utilizing the UK Biobank (UKB; replication cohort), we related plasma GDF15 (Olink) to incident ACD (N=35,673, 14-year follow-up, M=61±5), vascular dementia (VaD) and Alzheimer's disease dementia (AD).

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Background: Although many studies have shown that traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) regardless of their severity, are associated with a significantly increased risk of all-cause dementia, the specific pathophysiological mechanisms that underlie these associations remain poorly understood, resulting in discordance findings among different studies and contradictory claims in the current literature. In this study we investigated the effect of TBI and PTSD on the level of amyloid, tau, as well as markers of small vessel health including white matter hyperintensity and perivascular spaces and consequently assessed their effect on the cognitive function in order to understand the pathways through which TBI and PTSD may result in dementia.

Method: The participants in this study were MCI cases drawn from the ADNI-DOD (n=58).

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

National Center for Neurological Disorders, Shanghai, China.

Background: Whether lung function prospectively affects cognitive brain health independent of their overlapping factors remains largely unknown. This study aimed to investigate the longitudinal association between decreased lung function and cognitive brain health and to explore underlying biological and brain structural mechanisms.

Method: This population-based cohort included 43,1834 non-demented participants with spirometry from the UK Biobank.

View Article and Find Full Text PDF

Background: With the rapid aging of the US population, the prevalence of dementia is projected to double. The enactment of the Affordable Care Act and Medicaid expansion could create opportunities for detection and classification of dementia. There are trends of increasing dementia mortality, however, it is unknown whether Medicaid expansion increased the reporting of dementia as the underlying cause of death (UCOD) or as a multiple cause of death (MCOD) among the elderly.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, NSW, Australia.

Background: High-income countries (HICs) are over-represented in current global dementia incidence rates, skewing estimates. Variance in diagnostic methods between HICs and low- and middle-income countries (LMICs) is speculated to contribute to the regional differences in rates. Cohort Studies of Memory in an International Consortium (COSMIC) offers a unique opportunity to address these research inequalities by harmonising data from international studies, including representation from LMICs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!